Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients
Saved in:
| Published in: | AIDS Research and Treatment |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301673614966787 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | AIDS Research and Treatment |
| description | |
| discipline_display | Dermatology and Venereology |
| discipline_facet | Dermatology and Venereology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:76628 |
| institution | FRELIP |
| journal_source_facet | AIDS Research and Treatment |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients Dermatology and Venereology General Dermatology and Venereology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Dermatology and Venereology General Dermatology and Venereology Dermatology and Venereology General Dermatology and Venereology |
| subject_facet | Dermatology and Venereology General Dermatology and Venereology |
| title | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_auth | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_full | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_fullStr | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_full_unstemmed | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_short | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients |
| title_sort | bikswitch study: effectiveness and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (b/f/taf) from therapies not based on integrase inhibitors in virologically suppressed hiv-infected patients |
| topic | Dermatology and Venereology General Dermatology and Venereology |
| url | https://www.hindawi.com/journals/art/2025/8818830/ |